Risedronate compositions and their methods of use

Details for Australian Patent Application No. 2004322703 (hide)

International Classifications

Event Publications

15 February 2007 PCT application entered the National Phase

PCT publication WO2006/022755 Priority application(s): WO2006/022755

25 February 2010 Assignment before Grant

The Procter & Gamble Company The application has been assigned to Warner Chilcott Company, LLC 2005

2 December 2010 Application Accepted

Published as AU-B-2004322703

17 March 2011 Opposition Lodged

Apotex Pty Ltd has lodged an opposition against Warner Chilcott Company, LLC.

27 September 2012 Opposition Proceeding - Application Withdrawn

The opposition by Alphapharm Pty Limited against Warner Chilcott Company, LLC has been withdrawn.

27 September 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

Application withdrawn under section 141(1). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.